Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Enfusion Q2 2024 Adj. EPS $0.05 Misses $0.06 Estimate, Sales $49.455M Miss $50.046M Estimate

Author: Benzinga Newsdesk | August 06, 2024 06:39am
Enfusion (NYSE:ENFN) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.06 by 16.67 percent. The company reported quarterly sales of $49.455 million which missed the analyst consensus estimate of $50.046 million by 1.18 percent. This is a 15.76 percent increase over sales of $42.721 million the same period last year.

Posted In: ENFN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist